Atrial natriuretic peptide as a serum marker of right atrial enlargement and function in pulmonary hypertension

T. Sato, I. Tsujino, H. Ohira, N. Oyama-Manabe, M. Nishimura (Sapporo, Japan)

Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Session: Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Session type: Poster Discussion
Number: 1504
Disease area: Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Sato, I. Tsujino, H. Ohira, N. Oyama-Manabe, M. Nishimura (Sapporo, Japan). Atrial natriuretic peptide as a serum marker of right atrial enlargement and function in pulmonary hypertension. Eur Respir J 2012; 40: Suppl. 56, 1504

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The relationship between pro-BNP(brain natriuretic peptide), c-reactive protein(CRP) and right ventricular dysfunction in pulmonary embolism
Source: Annual Congress 2009 - Pulmonary embolism
Year: 2009


NT-proBNP can be used to detect right ventricular systolic dysfunction in pulmonary hypertension
Source: Eur Respir J 2007; 29: 737-744
Year: 2007



Role of B-type brain natriuretic peptide in the development of fluid retention and detection of right ventricular failure in COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 305s
Year: 2004

Identification of left ventricular systolic dysfunction or pulmonary hypertension in patients with asthma or chronic obstructive pulmonary disease by N-terminal pro-brain natriuretic peptide
Source: Annual Congress 2007 - New insight into the pathophysiology of asthma
Year: 2007


Echocardiography and N-terminal-pro-brain natriuretic peptide in assessment of left ventricular diastolic dysfunction in stable COPD in relation to disease severity
Source: International Congress 2017 – Current challenges in COPD evaluation
Year: 2017

The application of B-type natriuretic peptide level of the dyspneic patients ; differentiation between cor pulmonale and left ventricular dysfunction
Source: Eur Respir J 2003; 22: Suppl. 45, 583s
Year: 2003

N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism
Source: Eur Respir J 2003 Oct 01;22(4):649-653
Year: 2003



NT-proBNP reflects right ventricular structure and function in pulmonary hypertension
Source: Eur Respir J 2006; 28: 1190-1194
Year: 2006



Can brain natriuretic peptide (BNP) be a predictor for pulmonary arterial hypertension?
Source: Annual Congress 2007 - Pulmonary hypertension: diagnosis and treatment
Year: 2007



Plasma VEGF correlates with right ventricular function in pulmonary hypertension
Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases
Year: 2011


Atrial arrhythmias in pulmonary hypertension
Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension
Year: 2011


Right ventricular stiffness impairs right atrial function in pulmonary arterial hypertension
Source: Virtual Congress 2020 – Right ventricular function and pulmonary hypertension
Year: 2020




Effect of continuous positive airway pressure on plasma B-type natriuretic peptide in patients with respiratory failure and left ventricular dysfunction complicating acute myocardial infarction
Source: Annual Congress 2006 - Acute respiratory failure: diagnostic procedures and clinical management
Year: 2006

N-terminal-pro-brain natriuretic peptide as a haemodynamic marker in idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2005; 25: 509-513
Year: 2005



Brain natriuretic peptide (BNP) and right ventricular dysfunction predict survival in interstitial lung disease (ILD)
Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease
Year: 2008


Effect of noninvasive ventilation (NIV) on left ventricular (LV) function, B-type natriuretic peptide (BNP) and markers of systemic inflammation in patients with refractory heart failure
Source: Eur Respir J 2006; 28: Suppl. 50, 188s
Year: 2006

Effect of atrial septostomy on the survival of patients with severe pulmonary arterial hypertension
Source: Eur Respir J 2011; 38: 1343-1348
Year: 2011



Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension
Source: Eur Respir J 2010; 35: 95-104
Year: 2010



Macitentan in pulmonary hypertension due to left ventricular dysfunction
Source: Eur Respir J, 51 (2) 1701886; 10.1183/13993003.01886-2017
Year: 2018



Atrial flutter and fibrillation in patients with chronic pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012